BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31637452)

  • 1. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
    Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
    Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults.
    Wright M; Wickens CM; Di Ciano P; Sproule B; Fares A; Matheson J; Mann RE; Rehm J; Shuper PA; George TP; Huestis MA; Stoduto G; Le Foll B; Brands B
    Psychol Addict Behav; 2021 Aug; 35(5):536-552. PubMed ID: 34081489
    [No Abstract]   [Full Text] [Related]  

  • 3. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and residual mood and cognitive performance of young adults following smoked cannabis.
    Matheson J; Mann RE; Sproule B; Huestis MA; Wickens CM; Stoduto G; George TP; Rehm J; Le Foll B; Brands B
    Pharmacol Biochem Behav; 2020 Jul; 194():172937. PubMed ID: 32360692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects.
    Brands B; Mann RE; Wickens CM; Sproule B; Stoduto G; Sayer GS; Burston J; Pan JF; Matheson J; Stefan C; George TP; Huestis MA; Rehm J; Le Foll B
    Drug Alcohol Depend; 2019 Dec; 205():107641. PubMed ID: 31678833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    JAMA Netw Open; 2018 Nov; 1(7):e184841. PubMed ID: 30646391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.
    Schwope DM; Bosker WM; Ramaekers JG; Gorelick DA; Huestis MA
    J Anal Toxicol; 2012 Jul; 36(6):405-12. PubMed ID: 22589524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
    Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the acute effects of oral and vaporized cannabis among healthy adults.
    Sholler DJ; Strickland JC; Spindle TR; Weerts EM; Vandrey R
    Addict Biol; 2021 Jul; 26(4):e12968. PubMed ID: 32985064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
    Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in the subjective effects of oral Δ
    Fogel JS; Kelly TH; Westgate PM; Lile JA
    Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.
    Huestis MA; Boyd SJ; Heishman SJ; Preston KL; Bonnet D; Le Fur G; Gorelick DA
    Psychopharmacology (Berl); 2007 Nov; 194(4):505-15. PubMed ID: 17619859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.